minichart
December 13, 2024
A Presidential Boost for GLP-1s? Eli Lilly’s stock, recently hit by postelection volatility, could see a remarkable turnaround, driven in part by high-profile endorsements. Bernstein analysts point to positive signals that suggest the pharmaceutical...